Euroapi (EAPI.PA) Stock Price

Euroapi Price

Euronext·CLOSED
0.77
​
Market closed

Revenue at Euroapi has contracted by 1.4% per year over the past 6 years to 838.90 M EUR. Euroapi's net margin stands at -25.2%, down from -0.9% several years earlier. Analysts set a median price target of 2.66 EUR, implying 244.8% above the current price. Of 13 analysts, 0 rate the stock a buy — an overall Sell consensus.

Euroapi stock price

Access this data via the Eulerpool API

Euroapi business model & stock analysis

EUROAPI SA operates as a manufacturer and supplier of active pharmaceutical ingredient solutions for healthcare companies. The company is headquartered in Paris, Ile-De-France and currently employs 3,449 full-time employees. The company went IPO on 2022-05-06. The firm is engaged in the development, manufacture and supply of active-ingredient solutions to its healthcare partners. The company offers vitamin B12, prostaglandins, oligonucleotides, peptides, corticoids and hormones, anti-infectives, opiates (morphine, codeine, thebaine, etc. ), analgesics, etc. The firm also provides technologies and develops molecules through it’s Contract Development and Manufacturing Organization (CDMO). It’s CDMO services include Tides, Prostaglandins, Particle Engineering, Microbial Fermentation, Small Molecules Synthesis, Steroids and Hormones and Opiates & Controlled Substances. The company has production sites located in France, the United Kingdom, Germany, Italy and Hungary.

Frequently asked questions about Euroapi

Analysts currently set an average price target of 2.71 EUR for the Euroapi stock (median: 2.66 EUR), implying +250.8 % versus the latest price. The consensus is based on 13 analyst ratings.

13 analysts currently rate the Euroapi stock: 0 recommend buying, 5 holding and 8 selling. For 2026, analysts expect Euroapi to generate revenue of 748.26 M EUR and earnings per share of -1.05 EUR.

The Euroapi share (EAPI.PA) is listed on 7 stock exchanges, including: London (0EAP.L), Frankfurt (940.F), München (940.MU), Düsseldorf (940.DU), Paris (EAPI.PA).

The expected revenue of Euroapi is 748.26 M EUR. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Euroapi is -99.52 M EUR. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Euroapi is currently -0.73. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Euroapi stock.

The price-to-sales ratio (P/S) of Euroapi is currently 0.10. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Euroapi stock.

The Eulerpool Quality Score for Euroapi is 2/10.

The ISIN of Euroapi is FR0014008VX5. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of Euroapi is A3DJQ8. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of Euroapi is EAPI.PA. The ticker symbol is used to trade Euroapi shares on the stock exchange.

Fair ValueTerminal
0.65 EUR
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Pharmaceuticals
Number of shares
Employees
Revenue per Employee
243,229.92 EUR
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website euroapi.com
Country
Currency
EUR
Initial public offering
May 6, 2022
ISIN
FR0014008VX5
Cusip
F33077102
Market capitalization
73.80 M EURMicro Cap
52-Week Range
PEG
—
P/E ratio
P/Ee 2026
-0.73
P/Ee 2027
-2.11
P/Ee 2028
-4.86
P/Ee 2029
8.47
P/Ee 2030
5.10
P/S
P/Se
0.10
EV/EBIT
126.98
P/B Ratio
0.09
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-24.75 %
Last updated Oct 10, 2026, 7:56 PM

Euroapi Peer Group

Euroapi Ticker

DÜSSELDORF · 940.DUEURONEXT · EAPI.PAFRANKFURT · 940.FLONDON · 0EAP.LMUNICH · 940.MUPARIS · EAPI.PAOTC · EAPIF

Euroapi FIGI

EAPI:FP · BBG016JF56K0940:GR · BBG0175RNTT8940:GF · BBG0175RNTW4940:GD · BBG0175RNTX3940:GS · BBG0175RNTZ1940:GM · BBG0175RNV04940:GB · BBG0175RNV13EAPIEUR:EP · BBG0177HBGD6EAPIEUR:EZ · BBG0177HBGH2EAPIEUR:XS · BBG0177HBGJ0EAPIEUR:X2 · BBG0177HBGK8EAPIEUR:XH · BBG0177HBGM6

All fundamentals and in-depth analysis of Euroapi

Our stock analysis for Euroapi stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Euroapi. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.